BG106001A - Method of treating sleep apnoea - Google Patents

Method of treating sleep apnoea

Info

Publication number
BG106001A
BG106001A BG106001A BG10600101A BG106001A BG 106001 A BG106001 A BG 106001A BG 106001 A BG106001 A BG 106001A BG 10600101 A BG10600101 A BG 10600101A BG 106001 A BG106001 A BG 106001A
Authority
BG
Bulgaria
Prior art keywords
sleep apnoea
treating sleep
chlorphenyl
snoring
racemates
Prior art date
Application number
BG106001A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sharon Cheetham
David Heal
Carl Mendel
Timothy SEATON
Steve Weinstein
Anton Safer
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG106001A publication Critical patent/BG106001A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Harvester Elements (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG106001A 1999-03-19 2001-10-10 Method of treating sleep apnoea BG106001A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12518599P 1999-03-19 1999-03-19
PCT/US2000/007177 WO2000056314A1 (en) 1999-03-19 2000-03-17 Method of treating sleep apnoea

Publications (1)

Publication Number Publication Date
BG106001A true BG106001A (en) 2002-06-28

Family

ID=22418567

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106001A BG106001A (en) 1999-03-19 2001-10-10 Method of treating sleep apnoea

Country Status (26)

Country Link
US (1) US6365631B1 (pt)
EP (1) EP1169029B1 (pt)
JP (1) JP2003521469A (pt)
KR (1) KR100682291B1 (pt)
CN (1) CN1161114C (pt)
AT (1) ATE294573T1 (pt)
AU (1) AU773489B2 (pt)
BG (1) BG106001A (pt)
BR (1) BR0009080A (pt)
CA (1) CA2367022A1 (pt)
CZ (1) CZ298293B6 (pt)
DE (1) DE60019914T2 (pt)
DK (1) DK1169029T3 (pt)
ES (1) ES2244420T3 (pt)
HK (1) HK1044462B (pt)
HU (1) HUP0200501A3 (pt)
IL (2) IL145244A (pt)
MX (1) MXPA01009464A (pt)
NO (1) NO20014475L (pt)
NZ (1) NZ514014A (pt)
PL (1) PL359467A1 (pt)
PT (1) PT1169029E (pt)
SI (1) SI1169029T1 (pt)
SK (1) SK285308B6 (pt)
WO (1) WO2000056314A1 (pt)
ZA (1) ZA200107678B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
PL375032A1 (en) * 2002-10-05 2005-11-14 Hanmi Pharm.Co, Ltd. Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20050228052A1 (en) * 2004-01-29 2005-10-13 Barberich Timothy J Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine
DE602005018763D1 (de) * 2004-02-18 2010-02-25 Sepracor Inc Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
AU2007322477A1 (en) * 2006-11-22 2008-05-29 Sk Chemicals Co., Ltd. Inclusion complex of sibutramine and beta-cyclodextrin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
IL145244A0 (en) 2002-06-30
HK1044462B (zh) 2006-03-03
WO2000056314A1 (en) 2000-09-28
SI1169029T1 (sl) 2005-12-31
HUP0200501A2 (en) 2002-08-28
KR100682291B1 (ko) 2007-02-15
SK285308B6 (sk) 2006-10-05
IL145244A (en) 2006-12-10
EP1169029A1 (en) 2002-01-09
DK1169029T3 (da) 2005-08-29
NO20014475L (no) 2001-11-14
CZ20013280A3 (cs) 2002-07-17
DE60019914T2 (de) 2006-05-04
AU3896800A (en) 2000-10-09
CN1161114C (zh) 2004-08-11
CA2367022A1 (en) 2000-09-28
ES2244420T3 (es) 2005-12-16
IL177626A0 (en) 2006-12-31
PT1169029E (pt) 2005-08-31
MXPA01009464A (es) 2004-03-19
NO20014475D0 (no) 2001-09-14
DE60019914D1 (de) 2005-06-09
SK13382001A3 (sk) 2002-04-04
ATE294573T1 (de) 2005-05-15
PL359467A1 (en) 2004-08-23
NZ514014A (en) 2004-02-27
HUP0200501A3 (en) 2004-03-29
BR0009080A (pt) 2002-02-13
ZA200107678B (en) 2003-06-18
EP1169029A4 (en) 2004-01-21
US6365631B1 (en) 2002-04-02
EP1169029B1 (en) 2005-05-04
KR20010113847A (ko) 2001-12-28
AU773489B2 (en) 2004-05-27
CN1356897A (zh) 2002-07-03
JP2003521469A (ja) 2003-07-15
CZ298293B6 (cs) 2007-08-15
HK1044462A1 (en) 2002-10-25

Similar Documents

Publication Publication Date Title
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
IL152770A0 (en) Gabapentin analogues for sleep disorders
KR100239168B1 (en) Heterocyclic amines useful in the therapy of athma and inflammation of the respiratory tracts
HK1045455A1 (en) Method of treating eating disorders
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
IL128851A (en) Pharmaceutical composition for lowering the uric acid level in the human body
MX9805141A (es) Uso de inhibidores del intercambiador celular na+/h+ (nhe) para la preparacion de un farmaco para estimular la respiracion.
HUP0203132A3 (en) Method of producing n-[4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, hydrochloride and its hydrate
BG105999A (en) Treatment of osteoarthritis
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
MXPA01009469A (es) Tratamiento para disminuir la adhesividad de las plaquetas.
BG106000A (en) Treatment of hiatial hernia
BG105996A (en) Method of treating eating disorders